Literature DB >> 23783152

Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels.

Tina Bhutani1, Jillian W Wong, Bruce F Bebo, April W Armstrong.   

Abstract

IMPORTANCE: This article represents a real-world perspective on access to health care including the number and types of physicians seen by patients with psoriasis. It is important for practicing dermatologists to recognize patients who may be less likely to seek care for this multifaceted systemic disease as well as to be aware of reasons for not seeing physicians.
OBJECTIVES: To examine the relationship between psoriasis patient characteristics and access to health care and to determine out-of-pocket costs for psoriasis care.
DESIGN: Cross-sectional survey.
SETTING: Patients with psoriasis and psoriatic arthritis in the general community in the United States. PARTICIPANTS: A random sample of patients with psoriasis and psoriatic arthritis from more than 75,000 National Psoriasis Foundation members. MAIN OUTCOMES AND MEASURES: Number and type of physicians seen in the past 2 years and out-of-pocket health care expenses were measured.
RESULTS: Among 5604 patients with psoriasis and psoriatic arthritis, 92.4% had seen at least 1 physician in 2 years. Compared with males, female patients with psoriasis were 1.47 times more likely to seek care (adjusted odds ratio, 1.47; 95% CI, 1.18-1.83). Patients with private insurance and Medicare were more likely to seek care compared with uninsured patients (adjusted odds ratio, 3.02; 95% CI, 2.23-4.08 and 2.85; 1.91-4.24, respectively). Among patients with psoriasis seeking care, 78.3% were seeing specialists; 22% obtained care from primary care physicians. Primary reasons for not seeking treatments included giving up on disease treatment (27.6%) and prohibitive cost (21%). Compared with patients with mild disease, patients with severe psoriasis were more likely to seek a specialist for care (adjusted odds ratio, 1.64; 95% CI, 1.37-1.98). Patients spent an average of $2528 out-of-pocket per year for psoriasis care. CONCLUSIONS AND RELEVANCE: About one-quarter of patients seek psoriasis care from primary care physicians, and insurance status affects care-seeking patterns. Giving up on treatment and prohibitive costs remain primary reasons for not seeking care.

Entities:  

Mesh:

Year:  2013        PMID: 23783152     DOI: 10.1001/jamadermatol.2013.133

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  11 in total

1.  Association Between the Mental Health of Patients With Psoriasis and Their Satisfaction With Physicians.

Authors:  Charlotte Read; April W Armstrong
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

2.  Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study.

Authors:  Omer Karadag; Ediz Dalkilic; Gizem Ayan; Orhan Kucuksahin; Timucin Kasifoglu; Neslihan Yilmaz; Suleyman Serdar Koca; Veli Yazisiz; Pinar Talu Erten; Mehmet Sayarlioglu; Mustafa Ender Terzioglu; Sukran Erten; Umut Kalyoncu
Journal:  Clin Rheumatol       Date:  2021-09-03       Impact factor: 2.980

3.  Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study.

Authors:  Sofia Löfvendahl; Elke Theander; Åke Svensson; Katarina Steen Carlsson; Martin Englund; Ingemar F Petersson
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

4.  US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

Authors:  Mark G Lebwohl; Arthur Kavanaugh; April W Armstrong; Abby S Van Voorhees
Journal:  Am J Clin Dermatol       Date:  2016-02       Impact factor: 7.403

5.  Income disparities in healthcare use remain after controlling for healthcare need: evidence from Swedish register data on psoriasis and psoriatic arthritis.

Authors:  Sofia Löfvendahl; Anna Jöud; Ingemar F Petersson; Elke Theander; Åke Svensson; Katarina Steen Carlsson
Journal:  Eur J Health Econ       Date:  2017-05-19

6.  Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States.

Authors:  Alexis Ogdie; W Benjamin Nowell; Eddie Applegate; Kelly Gavigan; Shilpa Venkatachalam; Marie de la Cruz; Emuella Flood; Ethan J Schwartz; Beverly Romero; Peter Hur
Journal:  BMC Rheumatol       Date:  2020-01-10

7.  Psoriatic Arthritis Hospitalization Is Associated with Increased Health Care Charges: A Report from the National Inpatient Sample.

Authors:  Armaan Guraya; Eseosa J Sanwo; Karun M Nair; Sandhya Shri Kannayiram; Osahon N Idolor; Jesse O Odion
Journal:  Cureus       Date:  2020-12-25

8.  Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis.

Authors:  April Armstrong; Qian Xia; Anand Rojer John; Vardhaman Patel; Lauren Seigel
Journal:  Dermatol Ther (Heidelb)       Date:  2022-08-10

9.  Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.

Authors:  Lakshi M Aldredge; Melodie S Young
Journal:  J Dermatol Nurses Assoc       Date:  2016-02-12

10.  Gender differences in the adverse events' profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis.

Authors:  Delia Colombo; Emanuela Zagni; Mihaela Nica; Sara Rizzoli; Alessandra Ori; Gilberto Bellia
Journal:  Drug Des Devel Ther       Date:  2016-09-13       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.